Altos Labs
Biotechnology company focused on cellular rejuvenation programming
Altos is dedicated to unraveling the deep biology of cellular rejuvenation programming. Our mission is to restore cell health and resilience to reverse disease, injury, and disabilities that occur throughout life.
The Altos Institutes of Science will pursue deep scientific questions and integrate their findings into one collaborative research effort. The Altos Institute of Medicine will capture knowledge generated about cell health and programming and develop transformative medicines.
Altos Labs Leadership
• Wolf Reik, Director, Cambridge Institute of Science
Altos Labs Institute of Science Cambridge
• Maria Abad
• Kevin Chalut
• Martin Denzel
• Robin Franklin
• Giovanna Mallucci
• Ken Raj
• Manuel Serrano
Visit website: https://altoslabs.com/
Details last updated 20-Jan-2022
Mentioned in this Resource
Martin Denzel
Principal Investigator at AltosLabs and researcher at Max Planck Institute for Biology of Ageing
Robin Franklin
Principal Investigator at Altos Labs Cambridge Institute of Science, previously Professor of Stem Cell Medicine
Other people at Altos Labs
Hal Barron
President Research And Development at GSK, former president of research and development at Calico and incoming CEO at Altos Labs
Altos Labs News
El País interviews Altos Labs’ principal investigator Pura Muñoz Cánoves
El País - 27-Dec-2023
Altos labs with a $3-billion budget pave the way for reversing aging and extending healthy lifespan
Read more...Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit
Lifespan.io (LEAF) - 20-Jan-2023
Another reminder of the amount of research, with multiple approaches, about to go into clinical trials
Read more...Umbilical cord blood derived plasma improves health biomarkers
Lifespan.io (LEAF) - 06-Sep-2022
Plasma concentrate alters methylation clock reducing biological age
Read more...Ageing versus longevity: epigenetic age correlated with only a few ageing hallmarks
Live Forever Club - 08-Jun-2022
Mitochondrial dysfunction & stem cell exhaustion accelerated the epigenetic clock, but senescent cells & telomere length did not
Read more...The Observer interviews Morgan Levine about ageing and her move to Altos Labs
The Guardian - 07-May-2022
When it comes to lifespan, you cannot blame 100% on genetics, just 10-30%
Read more...Long-term partial reprogramming reversed ageing process in mice
The Guardian - 07-Mar-2022
Yamanaka factors restored youthfullness in aged cells, raised hope for new anti-ageing therapies
Read more...Altos Labs comes out of stealth with $3 billion of capital
Genetic Engineering & Biotechnology News (GEN) - 19-Jan-2022
Huge backing that cellular reprogramming can have a significant impact on health and ageing
Read more...
Topics mentioned on this page:
Rejuvenation
